Tredje AP fonden Has $14.90 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tredje AP fonden trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,536 shares of the medical equipment provider's stock after selling 3,000 shares during the quarter. Tredje AP fonden's holdings in Intuitive Surgical were worth $14,895,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the stock. State Street Corp lifted its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Geode Capital Management LLC raised its position in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC raised its position in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Finally, Wellington Management Group LLP raised its position in Intuitive Surgical by 1.7% during the third quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider's stock valued at $1,530,318,000 after acquiring an additional 53,383 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $20.52 on Thursday, hitting $476.78. 3,642,855 shares of the stock were exchanged, compared to its average volume of 1,433,311. The stock has a market capitalization of $169.82 billion, a price-to-earnings ratio of 74.38, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company's 50-day moving average price is $568.47 and its 200 day moving average price is $531.22.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 22,209 shares of company stock valued at $11,928,127. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages recently weighed in on ISRG. UBS Group raised their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Piper Sandler reaffirmed an "overweight" rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective on the stock. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.